Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults

This cohort study examines the association between use of 5α-reductase inhibitors and prostate cancer mortality among US Medicare beneficiaries.

Detalles Bibliográficos
Autores principales: Kumar, Abhishek, Nalawade, Vinit, Riviere, Paul, Sarkar, Reith R., Parsons, J. Kellog, Murphy, James D., Rose, Brent S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813580/
https://www.ncbi.nlm.nih.gov/pubmed/31626312
http://dx.doi.org/10.1001/jamanetworkopen.2019.13612
Descripción
Sumario:This cohort study examines the association between use of 5α-reductase inhibitors and prostate cancer mortality among US Medicare beneficiaries.

Ejemplares similares